FDA Inspection 1093550 — Baxalta Belgium Manufacturing SA
The FDA completed an inspection of Baxalta Belgium Manufacturing SA on May 31, 2019 in Lessines. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Biologics.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- May 31, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Lessines (Belgium)